Novartis intrathecal onasemnogene abeparvovec Phase III study meets primary endpoint in children and young adults with SMA
Ad hoc announcement pursuant to Art. 53 LR The Phase III STEER…
Tag: onasemnogene
Ad hoc announcement pursuant to Art. 53 LR The Phase III STEER…
